TD2 Precision Oncology | Biotech Hunter

About

Oncology Clinical Research

Areas of Focus

Categories

Clinical ResearchClinical ResearchClinical ResearchContract ResearchContract ResearchClinical ResearchClinical ResearchCg RegulatoryClinical ResearchSouthwestern U.S.

Team (17)

Alan Miller, MD, PhD

Chief Medical Officer

TD2 Precision Oncology

executive

Bill Donovan

Senior Vice President, Strategic Solutions

TD2 Precision Oncology

executive

Chad Souvignier

Vice President, Research Corporations Technologies

TD2 Precision Oncology

executive

Chris Clark

Chief Financial Officer

TD2 Precision Oncology

executive

Daniel D. Von Hoff, MD, FACP

Chief Development Strategist

TD2 Precision Oncology

team_member

Eric Tooker, JD

VP and General Counsel

TD2 Precision Oncology

executive

View all 17 team members →

Clinical Trials (1)

View all

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

Total Enrollment

24

By Phase

PHASE1/PHASE2: 1

By Status

COMPLETED: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2019

2020

2021

2022

2023

2024

Today

NCT04123470

Hover over trial bars to see details

Recent Trials

NCT04123470Collaborator

A Phase I/II Trial Investigating LOAd703 in Combination With Atezolizumab in Malignant Melanoma

PHASE1/PHASE2Completed

24 participants

Started: Jan 28, 2020 · Completed: Jul 30, 2023